TheraVet SA
ALVET | BR
Overview
Corporate Details
- ISIN(s):
- BE0974387194
- LEI:
- 984500804EBR3F1EFF71
- Country:
- Belgium
- Address:
- Avenue Jean Mermoz 32, 6041 Charleroi
- Website:
- https://www.thera.vet/en/home
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
TheraVet is a vet biotech company headquartered in Belgium (Jumet, Wallonia) with an US-based subsidiary. TheraVet's mission is to develop innovative, safe and effective treatments to improve the well-being and quality of life of companion animals suffering from osteoarticular diseases. TheraVet's main targets (indications & applications) are osteoarthritis, ligament & tendon injuries and bone surgery in cats and dogs as well as horses. TheraVet works in close collaboration with key opinion leaders in Belgium and abroad (France, Switzerland, United Kingdom & United States) to better address the ever-increasing needs of veterinary medicine.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-03-07 19:57 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 197.8 KB | |
| 2025-03-07 19:57 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 197.8 KB | |
| 2025-01-27 00:00 |
Regulatory News Service
CP 20250127 EURONEXT qualification apport actif H4 acquisition inversée.pdf
|
French | 644.6 KB | |
| 2024-12-12 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 193.7 KB | |
| 2024-12-12 00:00 |
Declaration of Voting Results & Voting Rights Announcements
CP_EGEIRO-121224_notification_de_transparence_ARTICLE 14.pdf
|
French | 193.7 KB | |
| 2024-12-05 18:00 |
Inside Information Statement
Informations privilégiées / Autres communiqués
|
French | 182.9 KB | |
| 2024-11-18 18:00 |
Board/Management Change
Inside Information / Other news releases
|
English | 191.3 KB | |
| 2024-11-18 18:00 |
Board/Management Change
Informations privilégiées / Autres communiqués
|
French | 165.7 KB | |
| 2024-11-18 00:00 |
Board/Management Change
EGEIRO-181124_CP démission EB.pdf
|
French | 165.7 KB | |
| 2024-10-29 07:30 |
Declaration of Voting Results & Voting Rights Announcements
Inside Information / Other news releases
|
English | 257.0 KB | |
| 2024-10-29 07:30 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 287.8 KB | |
| 2024-10-28 07:30 |
Declaration of Voting Results & Voting Rights Announcements
CP_TheraVet_AG_FR.pdf
|
French | 268.3 KB | |
| 2024-10-28 07:30 |
Declaration of Voting Results & Voting Rights Announcements
20241028_TheraVet_DDV.pdf
|
French | 223.8 KB | |
| 2024-10-28 07:30 |
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 243.8 KB | |
| 2024-10-17 07:30 |
Proxy Solicitation & Information Statements
TheraVet - AGE 2024 (28 OCT) - Procuration - Personnes Morales_Legal Entities.p…
|
French | 410.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-11-21 | Bastianelli Enrico | Board | Other | 200,000 | 380,000.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
AstraZeneca PLC | United Kingdom | AZN | |
|
Basilea Pharmaceutica AG | Switzerland | BSLN | |
|
Bayer AG | Germany | BAY | |
|
Biogened Spolka Akcyjna | Poland | BGD | |
|
Biotika A.S. | Slovakia | BSL | |
|
Bio Vitos Pharma AB | Sweden | BIOVIT | |
|
BOIRON | France | BOI | |
|
Bonyf N.V. | Belgium | MLBON | |
|
Bosnalijek d.d. Sarajevo | Bosnia and Herzegovina | BSNL | |
|
Calliditas Therapeutics | Sweden | CALTX |